Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug;37(4):879-882.
doi: 10.1111/fcp.12893. Epub 2023 Mar 17.

Investigating the link between drug consumption and adverse events reporting in France

Pauline Orhon  1 , Marion Robert  1 , Thomas Morand  1 , Jean-Luc Cracowski  1   2 , Charles Khouri  1   3
Affiliations

Investigating the link between drug consumption and adverse events reporting in France

Pauline Orhon et al. Fundam Clin Pharmacol. 2023 Aug.

Abstract

The objective of this study is to examine the potential association between drug use and adverse event reporting in France. A number of drug users and cases reported were extracted from the French Health Care Insurance database (Open Medic) and the French pharmacovigilance database. We performed two separate mixed-effect models (with a drug used or reporting rate as dependent variables) with a random intercept for drug classes. We selected 62 drugs from 10 drug classes, for which 177 364 cases were reported in the French pharmacovigilance database in 2020. The results showed a strong association between drug users and the number of reported cases in France among each drug class (P < 0.01). Within a drug class, the number of reported cases is, therefore, a proxy for the exposure to a given drug in the population. This finding could be useful to approximate and compare drug exposure from pharmacovigilance databases.

Keywords: adverse drug reactions; clinical pharmacology; drug utilization; epidemiology; pharmacovigilance.

PubMed Disclaimer

References

REFERENCES

    1. Montastruc JL, Sommet A, Bagheri H, Lapeyre-Mestre M. Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database: commentary. Br J Clin Pharmacol. 2011;72(6):905-908. doi:10.1111/j.1365-2125.2011.04037.x
    1. Raschi E, Moretti U, Salvo F, et al. Evolving roles of spontaneous reporting systems to assess and monitor drug safety. Pharmacovigilance; 2019. doi:10.5772/intechopen.79986
    1. Modgill V, Dormegny L, Lewis DJ. Reporting rates of adverse reactions to specialty care medicines exhibit a direct positive correlation with patient exposure: a lack of evidence for the Weber effect. Br J Clin Pharmacol. 2020;86(12):2393-2403. doi:10.1111/bcp.14342
    1. Open Medic. base complète sur les dépenses de médicaments interrégimes - data.gouv.fr. Accessed June 10, 2022. https://www.data.gouv.fr/fr/datasets/open-medic-base-complete-sur-les-de...
    1. Médicaments remboursés dans le cadre de la rétrocession hospitalière - Retroced'AM - de 2017 à 2020|L'Assurance Maladie. Accessed June 10, 2022. https://assurance-maladie.ameli.fr/etudes-et-donnees/medicaments-retroce...

MeSH terms

Grants and funding

LinkOut - more resources